The relationship between serum 25(OH)D and bone density and microarchitecture as measured by HR-pQCT

Osteoporos Int. 2015 Sep;26(9):2375-80. doi: 10.1007/s00198-015-3110-5. Epub 2015 Apr 8.

Abstract

The relation between serum 25-hydroxy vitamin D [25(OH)D] and bone quality is not well understood, particularly for high levels. We measured bone microarchitecture in three groups of people stratified by their serum 25(OH)D. There was a weak association of serum 25(OH)D and microarchitecture for this cross-sectional population, suggesting possible benefits to bone quality.

Introduction: Vitamin D plays an important role in bone and mineral metabolism, but the relation between serum 25(OH)D and bone quality is not well understood. Here, we present a cross-sectional study that investigated a convenience group of participants from an ongoing health initiative in Alberta, Canada, who have been receiving daily vitamin D supplementation.

Methods: A total of 105 participants were organized into three groups based on their serum 25(OH)D levels: low (<75 nmol/L), medium (75-175 nmol/L), and high (>175 nmol/L). They were also assessed with 25(OH)D as a continuous variable. Average daily supplementation was 7670 ± 438 IU, and the change in 25(OH)D ranged from 22 to 33 % during the period of receiving supplements. We used high-resolution peripheral quantitative computed tomography measurements at the radius and tibia to assess bone microarchitecture.

Results: Microarchitectural parameters were not strongly associated with serum 25(OH)D. In the tibia, there were fewer trabeculae (TbN; p = 0.015) and a non-significant trend toward thicker trabeculae (p = 0.067) of the high group. Body mass index (BMI) was negatively associated with serum 25(OH)D levels (p < 0.001) and PTH levels (p < 0.001). There was no clinically significant relationship detected between high serum 25(OH)D and high serum calcium.

Conclusion: These data suggest a weak relationship between serum 25(OH)D and bone microarchitecture in this population of mostly vitamin-D-sufficient participants, and there were no indications of negative effects related to the high supplementation levels. These data provided a basis to design and implement our 3-year dose-dependent randomized controlled trial investigating the effects of vitamin D supplementation on bone health outcomes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Bone Density / drug effects
  • Bone Density / physiology*
  • Calcium / blood
  • Cholecalciferol / pharmacology
  • Cross-Sectional Studies
  • Dietary Supplements
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects
  • Radius / diagnostic imaging
  • Radius / drug effects
  • Radius / physiology
  • Tibia / diagnostic imaging
  • Tibia / drug effects
  • Tibia / physiology
  • Tomography, X-Ray Computed / methods
  • Vitamin D / analogs & derivatives*
  • Vitamin D / blood
  • Vitamin D Deficiency / blood
  • Vitamin D Deficiency / physiopathology

Substances

  • Vitamin D
  • Cholecalciferol
  • 25-hydroxyvitamin D
  • Calcium